Qube Research & Technologies (QRT)’s Precigen PGEN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,532	Closed	-$17.5K	–	2907
2022 Q4	$17.5K	Buy	+11,532	New	+$19.8K	﹤0.01%	2243
2022 Q3	–	Sell	-57,921	Closed	-$78K	–	2890
2022 Q2	$78K	Sell	57,921 -540,765	-90%	-$802K	﹤0.01%	2022
2022 Q1	$1.26M	Buy	598,686 +523,227	+693%	+$1.27M	0.01%	1048
2021 Q4	$280K	Sell	75,459 -22,995	-23%	-$99K	﹤0.01%	1834
2021 Q3	$491K	Buy	98,454 +81,796	+491%	+$471K	0.01%	1220
2021 Q2	$109K	Sell	16,658 -37,444	-69%	-$262K	﹤0.01%	1935
2021 Q1	$373K	Buy	+54,102	New	+$457K	0.01%	1342

Other funds holding PGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PGEN Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Precigen (PGEN) in Q1 2023, closing a stake of 11,532 shares — an estimated $17.5K sold.

Qube Research & Technologies (QRT) first reported a position in PGEN in Q1 2021 and held it in 7 quarters. The position peaked at $1.26M in Q1 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

Qube Research & Technologies (QRT) reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 11,532 Precigen shares in Q1 2023, an estimated $17.5K.
Qube Research & Technologies (QRT) first reported a position in Precigen in Q1 2021 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Precigen position peaked at $1.26M in Q1 2022.
157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.